Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Contract Pharmacal Corp., 68369-68370 [2020-23845]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 209 / Wednesday, October 28, 2020 / Notices
(3) Pursuant to section 210.10(b)(3) of
the Commission’s Rules of Practice and
Procedure, 19 CFR 210.10(b)(3), the
presiding Administrative Law Judge
shall hold an early evidentiary hearing,
find facts, and issue an early decision,
within 100 days of institution except for
good cause shown, as to whether the
complainant has satisfied the economic
prong of the domestic industry
requirement. Notwithstanding any
Commission Rules to the contrary,
which are hereby waived, any such
decision should be issued in the form of
an initial determination (ID) under
Commission Rule 210.42(a)(3), 19 CFR
210.42(a)(3). The ID will become the
Commission’s final determination 30
days after the date of service of the ID
unless the Commission determines to
review the ID. Any such review will be
conducted in accordance with
Commission Rules 210.43, 210.44, and
210.45, 19 CFR 210.43, 210.44, and
210.45. The issuance of an early ID
finding that the complainant does not
satisfy the economic prong of the
domestic industry requirement shall
stay the investigation unless the
Commission orders otherwise; any other
decision shall not stay the investigation
or delay the issuance of a final ID
covering the other issues of the
investigation;
(4) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainant is:
Solas OLED Ltd., Suite 23, The Hyde
Building, Carrickmines, Dublin 18,
Ireland
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
Apple Inc., One Apple Park Way,
Cupertino, CA 95014
Dell Technologies Inc., One Dell Way,
Round Rock, TX 78682
LG Electronics Inc., LG Twin Tower 128
Yeoui-daero, Yeongdeungpo-gu,
Seoul, 07336, South Korea
LG Electronics USA, Inc., 1000 Sylvan
Ave., Englewood Cliffs, NJ 07632
LG Display America, Inc., 2540 North
First St, Suite 400, San Jose, CA 95131
LG Display Co., Ltd., LG Twin Tower
128 Yeoui-daero, Yeongdeungpo-gu,
Seoul, 07336, South Korea
Motorola Mobility LLC, 222 W
Merchandise Mart Plaza, Suite 1800,
Chicago, IL 60654
Samsung Electronics Co., Ltd., 129
Samsung-Ro, Yeongtong-gu, Suwonsi, Gyeonggi-do, 443–742, South
Korea
VerDate Sep<11>2014
18:29 Oct 27, 2020
Jkt 253001
Samsung Electronics America, Inc., 85
Challenger Rd., Ridgefield Park, NJ
07660
Samsung Display Co., Ltd., 1 SamsungRo, Giheung-gu, Yongin-si, GyeonggiDo, 17113, South Korea
Sony Electronics Inc., 16535 Via
Esprillo, San Diego, CA 92127
(c) The Office of Unfair Import
Investigations, U.S. International Trade
Commission, 500 E Street SW, Suite
401, Washington, DC 20436; and
(5) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), as
amended in 85 FR 15798 (March 19,
2020), such responses will be
considered by the Commission if
received not later than 20 days after the
date of service by the complainant of the
complaint and the notice of
investigation. Extensions of time for
submitting responses to the complaint
and the notice of investigation will not
be granted unless good cause therefor is
shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: October 22, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020–23786 Filed 10–27–20; 8:45 am]
BILLING CODE 7020–02–P
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
68369
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–735]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: Contract
Pharmacal Corp.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
pending applications according to
proposed regulations that, if finalized,
would govern the program of growing
marihuana for scientific and medical
research under DEA registration.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefor, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 28, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. To ensure proper handling of
comments, please reference Docket
No—DEA–735 in all correspondence,
including attachments.
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
file written comments on or objections
of the requested registration, as
provided in this notice. This notice does
not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
SUMMARY:
E:\FR\FM\28OCN1.SGM
28OCN1
68370
Federal Register / Vol. 85, No. 209 / Wednesday, October 28, 2020 / Notices
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA
proposes to conduct this evaluation in
the manner described in the rule
proposed at 85 FR 16292, published on
March 23, 2020, if finalized.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on August 21, 2020, Contract Pharmacal
Corp., 165 Oser Avenue, Hauppaugh,
New York 11788, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
Controlled substance
Marihuana Extract ..........
Marihuana .......................
Tetrahydrocannabinols ...
Drug
code
Schedule
7350
7360
7370
I
I
I
The applicants notice above applied
to become registered with DEA to grow
marihuana as a bulk manufacturer
subsequent to a 2020 DEA notice of
proposed rulemaking that provided
information on how DEA intends to
expand the number of registrations and
described the way it would oversee
those additional growers. If finalized,
the proposed rule would govern persons
seeking to become registered with DEA
to grow marihuana as a bulk
manufacturer, consistent with
applicable law. The notice of proposed
rulemaking is available at 85 FR 16292.
[FR Doc. 2020–23845 Filed 10–27–20; 8:45 am]
percent, falling below the 5.00 percent
threshold necessary to remain ‘‘on’’ EB.
Therefore, the EB period for Missouri
will end on October 10, 2020. The state
will remain in an ‘‘off’’ period for a
minimum of 13 weeks.
Information for Claimants
The duration of benefits payable in
the EB Program, and the terms and
conditions on which they are payable,
are governed by the Federal-State
Extended Unemployment Compensation
Act of 1970, as amended, and the
operating instructions issued to the
states by the U.S. Department of Labor.
In the case of a state ending an EB
period, the State Workforce Agency will
furnish a written notice to each
individual who is currently filing claims
for EB of the forthcoming termination of
the EB period and its effect on the
individual’s right to EB (20 CFR 615.13
(c)).
FOR FURTHER INFORMATION CONTACT: U.S.
Department of Labor, Employment and
Training Administration, Office of
Unemployment Insurance Room
S–4524, Attn: Thomas Stengle, 200
Constitution Avenue NW, Washington,
DC 20210, telephone number (202)–
693–2991 (this is not a toll-free number)
or by email: Stengle.Thomas@dol.gov.
Signed in Washington, DC.
John Pallasch,
Assistant Secretary for Employment and
Training.
[FR Doc. 2020–23815 Filed 10–27–20; 8:45 am]
BILLING CODE 4510–FW–P
Cherie Rogers,
Assistant Section Chief, Environmental
Defense Section, Environment and Natural
Resources Division.
[FR Doc. 2020–23809 Filed 10–27–20; 8:45 am]
BILLING CODE 4410–CW–P
DEPARTMENT OF LABOR
Employment and Training
Administration
Notice of a Change in Status of the
Extended Benefit (EB) Program for
Delaware
DEPARTMENT OF LABOR
Employment and Training
Administration
William T. McDermott,
Assistant Administrator.
Employment and Training
Administration, Labor.
ACTION: Notice.
AGENCY:
BILLING CODE 4410–09–P
Notice of a Change in Status of an
Extended Benefit (EB) Program for
Missouri
DEPARTMENT OF JUSTICE
AGENCY:
Employment and Training
Administration, Labor.
ACTION: Notice.
This notice announces a change in
benefit period eligibility under the EB
program for Delaware.
The following change has occurred
since the publication of the last notice
regarding the State’s EB status:
This notice announces a change in
benefit period eligibility under the EB
program for Missouri.
The following change has occurred
since the publication of the last notice
regarding the State’s EB status:
• Missouri’s 13-week insured
unemployment rate (IUR) for the week
ending September 19, 2020, was 4.97
Based on the data released by the Bureau
of Labor Statistics on September 18, 2020, the
seasonally-adjusted total unemployment rate
(TUR) for Delaware rose to exceed the 8.0%
threshold necessary to trigger ‘‘on’’ to a high
unemployment period in EB. Delaware
enacted emergency legislation mandating
that there would be a state ‘‘on’’ indicator for
weeks after September 19, 2020, if the
average TUR met the necessary criteria. As
Notice of Lodging Proposed Consent
Decree
jbell on DSKJLSW7X2PROD with NOTICES
Western District of Washington on
October 19, 2020.
This proposed Consent Decree
concerns a complaint filed by the
United States against Defendants Bobby
Wolford Trucking & Salvage, Inc. and
Karl Frederick Klock Pacific Bison, LLC,
pursuant to Clean Water Act Section
309, 33 U.S.C. 1319, to obtain injunctive
relief from and impose civil penalties
against the Defendants for violating the
Clean Water Act by discharging
pollutants without a permit into waters
of the United States. The proposed
Consent Decree resolves these
allegations by requiring the Defendants
to restore the impacted areas, perform
mitigation, and pay a civil penalty.
The Department of Justice will accept
written comments relating to this
proposed Consent Decree for thirty (30)
days from the date of publication of this
Notice. Please address comments to
Kent E. Hanson, Senior Attorney,
United States Department of Justice,
Environmental Defense Section, Post
Office Box 7611, Washington, DC
20044–7611, and refer to United States
v. Bobby Wolford Trucking & Salvage,
Inc., et al., DJ #90–5–1–1–19923.
The proposed Consent Decree may be
examined electronically at https://
www.justice.gov/enrd/consent-decrees.
Due to the ongoing Coronavirus/
COVID–19 emergency, the Clerk’s
Office, United States District Court for
the Western District of Washington, 700
Stewart Street, Suite 2310, Seattle, WA,
continues to have limited public access.
In accordance with Departmental
Policy, 28 CFR 50.7, notice is hereby
given that a proposed Consent Decree in
United States v. Bobby Wolford
Trucking & Salvage, Inc. and Karl
Frederick Klock Pacific Bison, LLC, Case
No. 2:18–cv–747–TSZ, was lodged with
the United States District Court for the
VerDate Sep<11>2014
18:29 Oct 27, 2020
Jkt 253001
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
E:\FR\FM\28OCN1.SGM
28OCN1
]]>Agencies
[Federal Register Volume 85, Number 209 (Wednesday, October 28, 2020)]
[Notices]
[Pages 68369-68370]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23845]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-735]
Bulk Manufacturer of Controlled Substances Application: Bulk
Manufacturer of Marihuana: Contract Pharmacal Corp.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) is providing notice
of an application it has received from an entity applying to be
registered to manufacture in bulk basic class(es) of controlled
substances listed in schedule I. DEA intends to evaluate this and other
pending applications according to proposed regulations that, if
finalized, would govern the program of growing marihuana for scientific
and medical research under DEA registration.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefor, may file written comments on or objections to
the issuance of the proposed registration on or before December 28,
2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. To ensure proper
handling of comments, please reference Docket No--DEA-735 in all
correspondence, including attachments.
SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA)
prohibits the cultivation and distribution of marihuana except by
persons who are registered under the CSA to do so for lawful purposes.
In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is
providing notice that the entity identified below has applied for
registration as a bulk manufacturer of schedule I controlled
substances. In response, registered bulk manufacturers of the affected
basic class(es), and applicants therefor, may file written comments on
or objections of the requested registration, as provided in this
notice. This notice does not constitute any evaluation or determination
of the merits of the application submitted.
The applicant plans to manufacture bulk active pharmaceutical
ingredients (APIs) for product development and distribution to DEA
registered researchers. If the application for registration is granted,
the registrant would not be authorized to conduct
[[Page 68370]]
other activity under this registration aside from those coincident
activities specifically authorized by DEA regulations. DEA will
evaluate the application for registration as a bulk manufacturer for
compliance with all applicable laws, treaties, and regulations and to
ensure adequate safeguards against diversion are in place.
As this applicant has applied to become registered as a bulk
manufacturer of marihuana, the application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA proposes to conduct this evaluation
in the manner described in the rule proposed at 85 FR 16292, published
on March 23, 2020, if finalized.
In accordance with 21 CFR 1301.33(a), DEA is providing notice that
on August 21, 2020, Contract Pharmacal Corp., 165 Oser Avenue,
Hauppaugh, New York 11788, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract...................... 7350 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
------------------------------------------------------------------------
The applicants notice above applied to become registered with DEA
to grow marihuana as a bulk manufacturer subsequent to a 2020 DEA
notice of proposed rulemaking that provided information on how DEA
intends to expand the number of registrations and described the way it
would oversee those additional growers. If finalized, the proposed rule
would govern persons seeking to become registered with DEA to grow
marihuana as a bulk manufacturer, consistent with applicable law. The
notice of proposed rulemaking is available at 85 FR 16292.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-23845 Filed 10-27-20; 8:45 am]
BILLING CODE 4410-09-P
